Last reviewed · How we verify

NCT03650673: COARDIG

A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis Symptoms

Recruiting now NA Last updated 30 September 2025
What this trial tests

NA trial testing Identification of subgroups of patients with early AD with risk of progression in Hand Osteoarthritis in 150 participants. Currently enrolling.

Timeline
15 July 2019
Primary endpoint
31 July 2028
31 October 2028

Quick facts

Lead sponsorUniversity Hospital, Montpellier
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment150
Start date15 July 2019
Primary completion31 July 2028
Estimated completion31 October 2028
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

Adults 18 to 60, any sex, with Hand Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The late-stage forms of degenerative osteoarthritis (OA) are very debilitating and less affordable to therapy. The main objective is to identify early onset symptoms of hand OA patients through imaging techniques (such as ultrasound and MRI). Our primary endpoint is to specify patients with high risk of radiological profression (X-ray).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hand Osteoarthritis

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03650673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing